Pulmonx (LUNG) Cash & Current Investments (2019 - 2025)

Pulmonx (LUNG) has 7 years of Cash & Current Investments data on file, last reported at $69.8 million in Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $69.8 million, down 31.27% year-over-year; the trailing twelve-month figure through Dec 2025 was $69.8 million (down 31.27% YoY), and the FY2025 annual result was $69.8 million, down 31.27% from the prior year.
• Cash & Current Investments slipped to $69.8 million in Q4 2025 per LUNG's latest filing, from $76.5 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $219.1 million in Q1 2021 and troughed at $69.8 million in Q4 2025.
• A 5-year average of $136.0 million and a median of $126.1 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2021 and 2025: Cash & Current Investments jumped 1248.85% in 2021, then plunged 31.27% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $180.0 million in 2021, then decreased by 21.61% to $141.1 million in 2022, then fell by 17.03% to $117.1 million in 2023, then slipped by 13.34% to $101.5 million in 2024, then sank by 31.27% to $69.8 million in 2025.
• Business Quant data shows LUNG's Cash & Current Investments at $69.8 million in Q4 2025, $76.5 million in Q3 2025, and $84.2 million in Q2 2025.